
Nephrology Fellow | University of Colorado | @CU_Kidney
Joined July 2024
- Tweets69
- Following324
- Followers68
- Likes80
Dr. Hinal Rathi, DO retweeted
Let’s go!!! Obi gets it done for membranous
fda.gov/drugs/news-events-hu…
The authors analyze the degree to which clinical specialties are shielded from, or threatened by, AI depending on how much of their work requires in-person physical interaction. Learn more: nejm.ai/3UDkrIv

ALT Bar chart titled "Limits to AI Substitution across Specialties: Composition of Medicare Part B Payments Including E&M Services." The chart shows percentages of "Physical," "E&M," and "Nonphysical" services across 15 medical specialties and all overall (US$44.9bn). Total 2023 Medicare Part B payments are shown in parentheses (US$ bn); amounts are in billions of U.S. dollars.
Dr. Hinal Rathi, DO retweeted
IgA nephropathy progresses to kidney failure in up to 50% of patients within 10–20 years.
On March 29th, the NEJM published the final 24-month data from APPLAUSE-IgAN and the results change the treatment landscape.
Here’s what every nephrologist needs to know 🧵
Barratt J et al. NEJM 2026. DOI: 10.1056/NEJMoa2600743
Dr. Hinal Rathi, DO retweeted
Should residents & fellows bill?
A single resident can provide >$300k/yr in uncompensated care due to outdated @CMSGov rules.
Our @NEJM paper proposes a competency-based framework to capture this revenue, improve trainee pay, and offset massive debt. #MedTwitter #MedEd #GME
We are pleased to share the publication of the KDIGO 2026 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD), a comprehensive update to the 2012 guideline.
Read the guideline in @Kidney_Int:
kdigo.co/KDIGO-Anemia-in-CKD…
Visit the KDIGO Anemia in CKD Guideline website to download the guideline, executive summary, and news release:
kdigo.org/guidelines/anemia-…
Co-chaired by Dr. Jodie Babitt (US) and Dr. Marcello Tonelli (CA), the guideline provides evidence-based recommendations for diagnosing and managing anemia across the CKD continuum, including dialysis and kidney transplantation.
“This guideline represents a major step forward in how we approach anemia in CKD,” said Dr. Babitt. “It emphasizes a systematic evaluation of anemia and iron deficiency, clearer guidance on when and how to use oral and intravenous iron, and integrates new evidence on emerging therapies while reinforcing the need to avoid overtreatment and to prioritize safety and shared decision-making.”
“This guideline reflects a decade of new evidence and the increasing complexity of anemia management in people with chronic kidney disease,” said Dr. Tonelli. “We evaluated a large body of randomized trial data across iron therapies, ESAs, HIF-PHIs, and transfusion strategies, with careful attention to both benefits and harms, to support consistent, evidence-informed anemia care across diverse healthcare systems, resource settings, and patient populations worldwide.”
#anemia #CKD
Dr. Hinal Rathi, DO retweeted
🔥Proud to share our latest #PKD prognostic model from CRISP IV
In ADPKD pts with normal eGFR we can predict probability of kidney failure 15 years later with C-index >0.8
Uses only TKV + data obtained in usual clinical care
@KUJGKI @KUMedCenter
@fouadchebib
Autosomal dominant polycystic kidney disease (ADPKD) is a common cause of kidney failure. This #ASNJASN study developed a multivariable predictive model for progression to kidney failure: kidney.pub/JASN0950
Dr. Hinal Rathi, DO retweeted
There’s a lot to be thankful for this Thanksgiving, but for #IgAN patients, this may be the most meaningful. 5 years ago we had ZERO drugs approved for this disease and today, we have 5 drugs with full or accelerated FDA approval!!
Thank you to all the patients who took a chance and participated in this and other clinical trials. You are why we are here today!!
otsuka-us.com/news/otsuka-re…
Dr. Hinal Rathi, DO retweeted
NIH funded study showing that select domains of cognition improve after kidney transplantation. Cognitive impairment in CKD is at least partially reversible! Thank you @AJKDonline.
Changes in Cognitive Function After Kidney Transplantation: A Longitudinal Cohort Study
buff.ly/49clWyB #OpenAccess
@AditiGuptaKUMC @KUNeph @KUALZ #VisualAbstract
Dr. Hinal Rathi, DO retweeted
Great to see our @uabmedicine medical student MS3 Nicole Tyler to present at @AHAScience ❤️ #Hypertension25 #prediabetes #arterial stiffness in patients <35 years. @Carmendemigue12 @AnastasiaSMihai @fjrios92 @guto_montezano @spjuraschek
Dr. Hinal Rathi, DO retweeted
Feeling grateful as I submit my applications for cardiology fellowship. Thankful for @uabmedicine Huntsville and @DrDudenbostel 's guidance and @patratumpa99 's unwavering support. On to the next chapter! ❤️🩹🫀🙏 #CardiologyFellowship #MedTwitter #Match2026 #FellowshipBound – at Huntsville, AL
Dr. Hinal Rathi, DO retweeted
Grateful and humbled to share that I’ve submitted my #CardiologyFellowship ERAS application!
AAMC ID: 13942592
Excited to connect with peers, fellows, and program leadership😇❤️🫀
#cardiologyfellowshipmatch #match2026
@ACCinTouch @SCAI @HRSonline @WomenCardiology @WomenAs1
Dr. Hinal Rathi, DO retweeted
Humbled and overflowing with gratitude for my program leadership at @namccares for believing in me for a chief resident position. Excited to lead with kindness with all round amazing friends and co-chiefs !!
#IMProud @ACPIMPhysicians @AAIMOnline
Dr. Hinal Rathi, DO retweeted
We’re discussing the latest science on the pathogenesis of IgAN and our speakers are providing an update on the current and emerging therapeutic landscape of IgAN. #NKFClinicals
Dr. Hinal Rathi, DO retweeted
It’s a PACKED room for “Lupus Nephritis: Still Hard to Diagnose and Harder to Manage” #NKFClinicals
Dr. Hinal Rathi, DO retweeted
Preliminary data suggests “some nuts, even with a variety of home treatments, have low P accessibility and may be considered for inclusion in the diet of people with CKD” shares Abigail Kisch during her oral poster presentation. #NKFClinicals
Dr. Hinal Rathi, DO retweeted
Providers! We have pre-printed patient materials that we want you to take with you. Take 10, take 50… it’s the simplest way to share free NKF resources with your patients. #NKFClinicals
Dr. Hinal Rathi, DO retweeted
#NKFClinicals is live in Boston this week!
Check out the abstracts in this special supplement:
bit.ly/428AIGf (FREE)
@NKF_NephPros
Dr. Hinal Rathi, DO retweeted
Grateful to @ACCinTouch for the opportunity to present our case on BRASH Sx -> Pacemaker non-capture this morning at #ACC2025 !! Thankful for my mentor @AbdelmohayminA and colleague @kaurdaniaMD for their collaboration !
@namccares #ACC25
Dr. Hinal Rathi, DO retweeted
#ACC25 Day 2, here is the summary of today’s trials (I haven’t included the follow-up extensions of Evolut Low Risk, Triluminate, and FAME 3). Today, I counted at least 2 NEJM, 4 Lancet, 1 Nature, 1 JAMA, 1 Circulation, and 1 JACC.
1. MIGHTy-Heart = In-home paramedic visits for heart failure did not reduce 30-day readmissions or improve health status compared to standard follow-up calls.
2. FRESH-UP = Limiting fluid intake showed no benefit for heart failure in the outpatient setting.
3. EQUIOX = Pulse oximeter readings differed significantly between patients with dark and light skin, compared to arterial blood oxygen saturation.
4. FAIR-HF2 = Intravenous iron with ferric carboxymaltose improved quality of life in HFrEF with iron deficiency but did not reduce heart failure hospitalizations or cardiovascular death.
5. BHF PROTECT-TAVI = Cerebral embolic protection during TAVI did not reduce stroke incidence within 72 hours.
6. ALIGN-AR = TAVR with the Trilogy valve in aortic regurgitation showed a 1-year mortality rate of 8.1%, well below the 25% noninferiority goal.
7. FLAVOUR II = AngioFFR, an AI-powered FFR method, was noninferior to IVUS in PCI outcomes for patients with significant stenosis.
8. SMART-CHOICE 3 = Clopidogrel monotherapy was more effective than aspirin in reducing major adverse cardiac and cerebrovascular events after PCI.
9. ALLEPRE = A secondary prevention program with counseling on heart medications and lifestyle changes reduced the primary composite outcome at five years post-ACS.
10. ALPACA = Lepodisiran, an extended-duration, small interfering RNA, reduced lipoprotein(a) concentrations in participants with elevated levels.
Dr. Hinal Rathi, DO retweeted
Loved representing @uabmedicine Huntsville @ACCinTouch . Thank you @DrDudenbostel for the support.
#ACC25 #Cardiology


































